Advenchen Laboratories, Llc
Clinical trials sponsored by Advenchen Laboratories, Llc, explained in plain language.
-
Hope for rare sarcoma: new pill shows promise in Late-Stage trial
Disease control Recruiting nowThis study tests a daily pill called AL3818 (anlotinib) for people with a rare cancer called alveolar soft part sarcoma (ASPS) that has spread. The goal is to see if the drug can shrink tumors or slow the cancer. About 325 adults with ASPS are being enrolled. Participants take th…
Phase: PHASE3 • Sponsor: Advenchen Laboratories, LLC • Aim: Disease control
Last updated May 26, 2026 05:33 UTC
-
New hope for hard-to-treat cancers: drug combo enters human trials
Disease control Recruiting nowThis study is testing a new combination of two drugs (AL8326 and toripalimab) in people with advanced solid tumors that have stopped responding to standard therapy or have no other treatment options. The trial has two parts: first, finding the safest and most effective dose, and …
Phase: PHASE1, PHASE2 • Sponsor: Advenchen Laboratories, LLC • Aim: Disease control
Last updated May 26, 2026 05:31 UTC